 | • レポートコード：D005-00049 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、筋萎縮性側索硬化症の世界市場を広く調査・分析し、今後の市場展望をまとめております。筋萎縮性側索硬化症の種類別市場規模（幹細胞療法、化学療法）、用途別市場規模（病院、診断センター、クリニック、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GNT Pharma、Apotex、Amkor Pharma、Synthetic Biologics、Biogen、Avicena、Sanofi、Mitsubishi Tanabe Pharma、Mylan Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・筋萎縮性側索硬化症の北米市場（アメリカ、カナダ、メキシコ） ・筋萎縮性側索硬化症のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・筋萎縮性側索硬化症のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・筋萎縮性側索硬化症の南米市場（ブラジル、アルゼンチン） ・筋萎縮性側索硬化症の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：幹細胞療法、化学療法 ・用途別分析：病院、診断センター、クリニック、小売薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Amyotrophic Lateral Sclerosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 15.0% in the forecast period of 2020 to 2025 and will expected to reach USD 338 million by 2025, from USD 193 million in 2019.
The Amyotrophic Lateral Sclerosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Amyotrophic Lateral Sclerosis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Amyotrophic Lateral Sclerosis market has been segmented into:
Stem Cell Therapy
Chemotherapy
By Application, Amyotrophic Lateral Sclerosis has been segmented into:
Hospitals
Diagnostic Centres
Clinics
Retail Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Amyotrophic Lateral Sclerosis market presented in the report. This section sheds light on the sales growth of different regional and country-level Amyotrophic Lateral Sclerosis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Amyotrophic Lateral Sclerosis market.
The report offers in-depth assessment of the growth and other aspects of the Amyotrophic Lateral Sclerosis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Amyotrophic Lateral Sclerosis Market Share Analysis
Amyotrophic Lateral Sclerosis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Amyotrophic Lateral Sclerosis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Amyotrophic Lateral Sclerosis sales, revenue and market share for each player covered in this report.
The major players covered in Amyotrophic Lateral Sclerosis are:
GNT Pharma
Apotex
Amkor Pharma
Synthetic Biologics
Biogen
Avicena
Sanofi
Mitsubishi Tanabe Pharma
Mylan Pharmaceuticals
Table of Contents
1 Amyotrophic Lateral Sclerosis Market Overview
1.1 Product Overview and Scope of Amyotrophic Lateral Sclerosis
1.2 Classification of Amyotrophic Lateral Sclerosis by Type
1.2.1 Global Amyotrophic Lateral Sclerosis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Amyotrophic Lateral Sclerosis Revenue Market Share by Type in 2019
1.2.3 Stem Cell Therapy
1.2.4 Chemotherapy
1.3 Global Amyotrophic Lateral Sclerosis Market by Application
1.3.1 Overview: Global Amyotrophic Lateral Sclerosis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Diagnostic Centres
1.3.4 Clinics
1.3.5 Retail Pharmacies
1.4 Global Amyotrophic Lateral Sclerosis Market by Regions
1.4.1 Global Amyotrophic Lateral Sclerosis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Amyotrophic Lateral Sclerosis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Amyotrophic Lateral Sclerosis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Amyotrophic Lateral Sclerosis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Amyotrophic Lateral Sclerosis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Amyotrophic Lateral Sclerosis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Amyotrophic Lateral Sclerosis Status and Prospect (2015-2025)
2 Company Profiles
2.1 GNT Pharma
2.1.1 GNT Pharma Details
2.1.2 GNT Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GNT Pharma SWOT Analysis
2.1.4 GNT Pharma Product and Services
2.1.5 GNT Pharma Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2018-2019)
2.2 Apotex
2.2.1 Apotex Details
2.2.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Apotex SWOT Analysis
2.2.4 Apotex Product and Services
2.2.5 Apotex Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amkor Pharma
2.3.1 Amkor Pharma Details
2.3.2 Amkor Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amkor Pharma SWOT Analysis
2.3.4 Amkor Pharma Product and Services
2.3.5 Amkor Pharma Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2018-2019)
2.4 Synthetic Biologics
2.4.1 Synthetic Biologics Details
2.4.2 Synthetic Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Synthetic Biologics SWOT Analysis
2.4.4 Synthetic Biologics Product and Services
2.4.5 Synthetic Biologics Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biogen
2.5.1 Biogen Details
2.5.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biogen SWOT Analysis
2.5.4 Biogen Product and Services
2.5.5 Biogen Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2018-2019)
2.6 Avicena
2.6.1 Avicena Details
2.6.2 Avicena Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Avicena SWOT Analysis
2.6.4 Avicena Product and Services
2.6.5 Avicena Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sanofi SWOT Analysis
2.7.4 Sanofi Product and Services
2.7.5 Sanofi Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2018-2019)
2.8 Mitsubishi Tanabe Pharma
2.8.1 Mitsubishi Tanabe Pharma Details
2.8.2 Mitsubishi Tanabe Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Mitsubishi Tanabe Pharma SWOT Analysis
2.8.4 Mitsubishi Tanabe Pharma Product and Services
2.8.5 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mylan Pharmaceuticals
2.9.1 Mylan Pharmaceuticals Details
2.9.2 Mylan Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mylan Pharmaceuticals SWOT Analysis
2.9.4 Mylan Pharmaceuticals Product and Services
2.9.5 Mylan Pharmaceuticals Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Amyotrophic Lateral Sclerosis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Amyotrophic Lateral Sclerosis Players Market Share
3.2.2 Top 10 Amyotrophic Lateral Sclerosis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Amyotrophic Lateral Sclerosis Revenue and Market Share by Regions
4.2 North America Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
4.3 Europe Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
4.5 South America Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
5 North America Amyotrophic Lateral Sclerosis Revenue by Countries
5.1 North America Amyotrophic Lateral Sclerosis Revenue by Countries (2015-2020)
5.2 USA Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
5.3 Canada Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
5.4 Mexico Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
6 Europe Amyotrophic Lateral Sclerosis Revenue by Countries
6.1 Europe Amyotrophic Lateral Sclerosis Revenue by Countries (2015-2020)
6.2 Germany Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
6.3 UK Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
6.4 France Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
6.5 Russia Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
6.6 Italy Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Amyotrophic Lateral Sclerosis Revenue by Countries
7.1 Asia-Pacific Amyotrophic Lateral Sclerosis Revenue by Countries (2015-2020)
7.2 China Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
7.3 Japan Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
7.4 Korea Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
7.5 India Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
8 South America Amyotrophic Lateral Sclerosis Revenue by Countries
8.1 South America Amyotrophic Lateral Sclerosis Revenue by Countries (2015-2020)
8.2 Brazil Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
8.3 Argentina Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Amyotrophic Lateral Sclerosis by Countries
9.1 Middle East & Africa Amyotrophic Lateral Sclerosis Revenue by Countries (2015-2020)
9.2 Saudi Arabia Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
9.3 UAE Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
9.4 Egypt Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
9.5 South Africa Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Amyotrophic Lateral Sclerosis Revenue and Market Share by Type (2015-2020)
10.2 Global Amyotrophic Lateral Sclerosis Market Forecast by Type (2019-2024)
10.3 Stem Cell Therapy Revenue Growth Rate (2015-2025)
10.4 Chemotherapy Revenue Growth Rate (2015-2025)
11 Global Amyotrophic Lateral Sclerosis Market Segment by Application
11.1 Global Amyotrophic Lateral Sclerosis Revenue Market Share by Application (2015-2020)
11.2 Amyotrophic Lateral Sclerosis Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Diagnostic Centres Revenue Growth (2015-2020)
11.5 Clinics Revenue Growth (2015-2020)
11.6 Retail Pharmacies Revenue Growth (2015-2020)
12 Global Amyotrophic Lateral Sclerosis Market Size Forecast (2021-2025)
12.1 Global Amyotrophic Lateral Sclerosis Market Size Forecast (2021-2025)
12.2 Global Amyotrophic Lateral Sclerosis Market Forecast by Regions (2021-2025)
12.3 North America Amyotrophic Lateral Sclerosis Revenue Market Forecast (2021-2025)
12.4 Europe Amyotrophic Lateral Sclerosis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Amyotrophic Lateral Sclerosis Revenue Market Forecast (2021-2025)
12.6 South America Amyotrophic Lateral Sclerosis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Amyotrophic Lateral Sclerosis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Amyotrophic Lateral Sclerosis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Amyotrophic Lateral Sclerosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Amyotrophic Lateral Sclerosis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Amyotrophic Lateral Sclerosis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GNT Pharma Corporate Information, Location and Competitors
Table 6. GNT Pharma Amyotrophic Lateral Sclerosis Major Business
Table 7. GNT Pharma Amyotrophic Lateral Sclerosis Total Revenue (USD Million) (2017-2018)
Table 8. GNT Pharma SWOT Analysis
Table 9. GNT Pharma Amyotrophic Lateral Sclerosis Product and Solutions
Table 10. GNT Pharma Amyotrophic Lateral Sclerosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Apotex Corporate Information, Location and Competitors
Table 12. Apotex Amyotrophic Lateral Sclerosis Major Business
Table 13. Apotex Amyotrophic Lateral Sclerosis Total Revenue (USD Million) (2018-2019)
Table 14. Apotex SWOT Analysis
Table 15. Apotex Amyotrophic Lateral Sclerosis Product and Solutions
Table 16. Apotex Amyotrophic Lateral Sclerosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Amkor Pharma Corporate Information, Location and Competitors
Table 18. Amkor Pharma Amyotrophic Lateral Sclerosis Major Business
Table 19. Amkor Pharma Amyotrophic Lateral Sclerosis Total Revenue (USD Million) (2017-2018)
Table 20. Amkor Pharma SWOT Analysis
Table 21. Amkor Pharma Amyotrophic Lateral Sclerosis Product and Solutions
Table 22. Amkor Pharma Amyotrophic Lateral Sclerosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Synthetic Biologics Corporate Information, Location and Competitors
Table 24. Synthetic Biologics Amyotrophic Lateral Sclerosis Major Business
Table 25. Synthetic Biologics Amyotrophic Lateral Sclerosis Total Revenue (USD Million) (2017-2018)
Table 26. Synthetic Biologics SWOT Analysis
Table 27. Synthetic Biologics Amyotrophic Lateral Sclerosis Product and Solutions
Table 28. Synthetic Biologics Amyotrophic Lateral Sclerosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Biogen Corporate Information, Location and Competitors
Table 30. Biogen Amyotrophic Lateral Sclerosis Major Business
Table 31. Biogen Amyotrophic Lateral Sclerosis Total Revenue (USD Million) (2017-2018)
Table 32. Biogen SWOT Analysis
Table 33. Biogen Amyotrophic Lateral Sclerosis Product and Solutions
Table 34. Biogen Amyotrophic Lateral Sclerosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Avicena Corporate Information, Location and Competitors
Table 36. Avicena Amyotrophic Lateral Sclerosis Major Business
Table 37. Avicena Amyotrophic Lateral Sclerosis Total Revenue (USD Million) (2017-2018)
Table 38. Avicena SWOT Analysis
Table 39. Avicena Amyotrophic Lateral Sclerosis Product and Solutions
Table 40. Avicena Amyotrophic Lateral Sclerosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sanofi Corporate Information, Location and Competitors
Table 42. Sanofi Amyotrophic Lateral Sclerosis Major Business
Table 43. Sanofi Amyotrophic Lateral Sclerosis Total Revenue (USD Million) (2017-2018)
Table 44. Sanofi SWOT Analysis
Table 45. Sanofi Amyotrophic Lateral Sclerosis Product and Solutions
Table 46. Sanofi Amyotrophic Lateral Sclerosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Mitsubishi Tanabe Pharma Corporate Information, Location and Competitors
Table 48. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Major Business
Table 49. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Total Revenue (USD Million) (2017-2018)
Table 50. Mitsubishi Tanabe Pharma SWOT Analysis
Table 51. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Product and Solutions
Table 52. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Mylan Pharmaceuticals Corporate Information, Location and Competitors
Table 54. Mylan Pharmaceuticals Amyotrophic Lateral Sclerosis Major Business
Table 55. Mylan Pharmaceuticals Amyotrophic Lateral Sclerosis Total Revenue (USD Million) (2017-2018)
Table 56. Mylan Pharmaceuticals SWOT Analysis
Table 57. Mylan Pharmaceuticals Amyotrophic Lateral Sclerosis Product and Solutions
Table 58. Mylan Pharmaceuticals Amyotrophic Lateral Sclerosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Amyotrophic Lateral Sclerosis Revenue (Million USD) by Players (2015-2020)
Table 60. Global Amyotrophic Lateral Sclerosis Revenue Share by Players (2015-2020)
Table 61. Global Amyotrophic Lateral Sclerosis Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Amyotrophic Lateral Sclerosis Revenue Market Share by Regions (2015-2020)
Table 63. North America Amyotrophic Lateral Sclerosis Revenue by Countries (2015-2020)
Table 64. North America Amyotrophic Lateral Sclerosis Revenue Market Share by Countries (2015-2020)
Table 65. Europe Amyotrophic Lateral Sclerosis Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Amyotrophic Lateral Sclerosis Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Amyotrophic Lateral Sclerosis Revenue by Countries (2015-2020)
Table 68. South America Amyotrophic Lateral Sclerosis Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Amyotrophic Lateral Sclerosis Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Amyotrophic Lateral Sclerosis Revenue Market Share by Countries (2015-2020)
Table 71. Global Amyotrophic Lateral Sclerosis Revenue (Million USD) by Type (2015-2020)
Table 72. Global Amyotrophic Lateral Sclerosis Revenue Share by Type (2015-2020)
Table 73. Global Amyotrophic Lateral Sclerosis Revenue Forecast by Type (2021-2025)
Table 74. Global Amyotrophic Lateral Sclerosis Revenue by Application (2015-2020)
Table 75. Global Amyotrophic Lateral Sclerosis Revenue Share by Application (2015-2020)
Table 76. Global Amyotrophic Lateral Sclerosis Revenue Forecast by Application (2021-2025)
Table 77. Global Amyotrophic Lateral Sclerosis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Amyotrophic Lateral Sclerosis Picture
Figure 2. Global Amyotrophic Lateral Sclerosis Revenue Market Share by Type in 2019
Figure 3. Stem Cell Therapy Picture
Figure 4. Chemotherapy Picture
Figure 5. Amyotrophic Lateral Sclerosis Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Diagnostic Centres Picture
Figure 8. Clinics Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Global Amyotrophic Lateral Sclerosis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Amyotrophic Lateral Sclerosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Amyotrophic Lateral Sclerosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Amyotrophic Lateral Sclerosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Amyotrophic Lateral Sclerosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Amyotrophic Lateral Sclerosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Amyotrophic Lateral Sclerosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Amyotrophic Lateral Sclerosis Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Amyotrophic Lateral Sclerosis Revenue Market Share in 2019
Figure 19. Global Top 10 Players Amyotrophic Lateral Sclerosis Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Amyotrophic Lateral Sclerosis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Amyotrophic Lateral Sclerosis Revenue Market Share by Regions (2015-2020)
Figure 23. Global Amyotrophic Lateral Sclerosis Revenue Market Share by Regions in 2018
Figure 24. North America Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 25. Europe Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 27. South America Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 29. North America Amyotrophic Lateral Sclerosis Revenue Market Share by Countries (2015-2020)
Figure 30. North America Amyotrophic Lateral Sclerosis Revenue Market Share by Countries in 2019
Figure 31. USA Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 32. Canada Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 34. Europe Amyotrophic Lateral Sclerosis Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Amyotrophic Lateral Sclerosis Revenue Market Share by Countries in 2019
Figure 36. Germany Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 37. UK Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 38. France Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 39. Russia Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 40. Italy Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Amyotrophic Lateral Sclerosis Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Amyotrophic Lateral Sclerosis Revenue Market Share by Countries in 2019
Figure 43. China Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 44. Japan Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 45. Korea Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 46. India Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 48. South America Amyotrophic Lateral Sclerosis Revenue Market Share by Countries (2015-2020)
Figure 49. South America Amyotrophic Lateral Sclerosis Revenue Market Share by Countries in 2019
Figure 50. Brazil Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Amyotrophic Lateral Sclerosis Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Amyotrophic Lateral Sclerosis Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 55. UAE Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)
Figure 58. Global Amyotrophic Lateral Sclerosis Revenue Share by Type (2015-2020)
Figure 59. Global Amyotrophic Lateral Sclerosis Revenue Share by Type in 2019
Figure 60. Global Amyotrophic Lateral Sclerosis Market Share Forecast by Type (2021-2025)
Figure 61. Global Stem Cell Therapy Revenue Growth Rate (2015-2020)
Figure 62. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 63. Global Amyotrophic Lateral Sclerosis Revenue Share by Application (2015-2020)
Figure 64. Global Amyotrophic Lateral Sclerosis Revenue Share by Application in 2019
Figure 65. Global Amyotrophic Lateral Sclerosis Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 67. Global Diagnostic Centres Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Amyotrophic Lateral Sclerosis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Amyotrophic Lateral Sclerosis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Amyotrophic Lateral Sclerosis Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Amyotrophic Lateral Sclerosis Revenue Market Forecast (2021-2025)
Figure 74. Europe Amyotrophic Lateral Sclerosis Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Amyotrophic Lateral Sclerosis Revenue Market Forecast (2021-2025)
Figure 76. South America Amyotrophic Lateral Sclerosis Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Amyotrophic Lateral Sclerosis Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
患者用ラテラルトランスファーの世界市場レポート2020 The report is about Patient Lateral Transfer market. Performing lateral patient transfers is a common task in the daily tasks of healthcare workers. Although somewhat routine and performed in high quantities, transferring patients from one surface to another can become complicated and cause potentia…- ラテラルティーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lateral Tees market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lateral Tees market report provi…
- マイクロおよび機械化灌漑システムの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Micro and Mechanized Irrigation Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.8% in the forecast period of 2020 to 2025 and will expected to reach USD 16340 million by 2025, from USD 11660 million in 2019. Th…
- 動物幹細胞療法の世界市場レポート2020 Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three …
- 限局性自己免疫疾患診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Localized Autoimmune Disease Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Loca…